The risk of cardiovascular and cerebrovascular disease significantly increased for COVID-19 patients during the 12 months following their positive test. Source: AAO
This multicenter registry study showed no differences in graft failure or rejection rates for patients with Fuchs dystrophy undergoing DSAEK who received gender or H-Y matched donor corneas compared to patients with mismatched donor corneas. Source: AAO
A study shows greater improvement in visual acuity with internal limiting membrane (ILM) peeling vs. the inverted ILM flap technique to repair idiopathic macular holes. Source: AAO
This study identified anterior segment OCT biometric parameters that are risk factors for progression from primary angle-closure suspect to more severe disease. Source: AAO
This study evaluated the efficacy and safety outcomes of eyes with neurotrophic keratitis (NK) that underwent a course of cenegermin-bkbj (Oxervate) in the presence of a bandage contact lens (BCL). Source: AAO
This week in the news, erectile dysfunction (ED) drugs can have serious ocular effects, a new trial is assessing diabetic macular edema (DME) in underserved populations, and more retinal vein occlusions are seen after COVID-19 diagnosis. Source: AAO
Results from the phase 3 ADAPT trial of the efficacy and safety of efgartigimod in patients with generalized myasthenia gravis (MG) are now available. Source: AAO
Patients with metastatic uveal melanoma who received tebentafusp had significantly higher 1-year survival rates than patients who received pembrolizumab, ipilimumab, or dacarbazine. Source: AAO
Both current patient data and cases reported in the literature were assessed to ascertain the frequency and presentation of myasthenia gravis in the setting of immune checkpoint inhibitor therapy. Source: AAO
Investigators evaluated whether the psychological effects of having an artificial eye and patient coping strategies are connected to depression and anxiety. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
